IPO registrations (S-1, F-1) · Registrants

ZYMOGENETICS INC

SEC CIK
1129425 · filings on EDGAR ↗
Registration
Form S-1, first filed 2001-09-10, last 2002-01-31; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2002-02-01
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
WA
Business address
1201 EASTLAKE AVENUE E, Seattle, WA 98102
EIN
91-1144498
EDGAR entity type
operating
Insiders and CEO pay
ZYMOGENETICS INC on the corporate pages

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 2002-01-31)
Final price
$12.00 per share, within the range (424B4 filed 2002-02-01, an initial public offering)
Shares sold
10,000,000
Gross proceeds
$120,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ZGEN
Lead underwriters
Lehman Brothers; Merrill Lynch (3,132,500 shares); Bear Stearns (1,611,000 shares); Pacific Growth Equities, Inc (1,074,000 shares)
Syndicate
Cantor Fitzgerald (100,000); A.G. Edwards (100,000); McAdams Wright Ragen, Inc (100,000); Prudential Securities (100,000); Cowen (100,000); Wells Fargo (100,000); Brean Murray & Co., Inc (50,000); Chatsworth Securities LLC (50,000); Fahnestock & Co. Inc (50,000); Fortis Securities Inc (50,000); C.L. King & Associates (50,000); Leerink Partners (50,000); Utendahl Capital Partners, L.P (50,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 5

FiledFormWhat it isName as filedEDGAR
2001-09-10S-1S-1 (registration)ZYMOGENETICS INC0001032210-01-501085 ↗
2001-11-02S-1/AS-1/A (amendment)ZYMOGENETICS INC0001032210-01-501267 ↗
2002-01-10S-1/AS-1/A (amendment)ZYMOGENETICS INC0001032210-02-000018 ↗
2002-01-31S-1/AS-1/A (amendment)ZYMOGENETICS INC0001032210-02-000099 ↗
2002-02-01424B4424B4 (final prospectus)ZYMOGENETICS INC0001032210-02-000106 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2002-01-31S-1/Aregistration statement$12.00–$14.0010,000,000-Nasdaq ZGEN5primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 5document ↗
2002-02-01424B4final prospectus$12.0010,000,000$120,000,000Nasdaq ZGEN17primary document; price sentence, shares headline, proceeds table, underwriting table 16, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
CARTER BRUCE L ADirector; Director,Officer; OfficerCEO & Chairman of the Board; President & CEO; President & CEO & Board Chair142006–2010
HENELL FREDRIKOfficerSr VP Business Development42006
JOHNSON JAMES AOfficerExecutive VP and CFO; Senior Vice President and CFO; Senior VP and CFO172006–2010
OHRSTROM JAN KOfficerSr. VP, Business Development; Sr. VP, Commercial Operations72006–2007
ONETTO NICOLEOfficerSr. VP & Chief Medical Officer52006–2009
SHEMA SUZANNE MOfficerSenior VP, General Counsel; SVP Intellectual Prop. & Legal142006–2009
WILLIAMS DOUGLAS EDirector; Director,Officer; OfficerCEO; Chief Executive Officer; Executive VP R&D and CSO; President and CSO132006–2010
YOUNG MARK DOfficerSr VP, Technical Operations92006
HEMBERGER JUDITH ADirector52006–2009
Dwyer Michael JOfficerSenior VP, Marketing and Sales; Senior VP, Marketing & Sales62006–2009
HIMES VAUGHN BOfficerSr. VP, Technical Operation; SR VP, Technical Operations62006–2009
Harper James ADirector72006–2010
HIRSH DAVID IDirector62006–2010
LEFF JONATHAN SDirector; Director,TenPercentOwner142006–2010
MacCallum DavidDirector72006–2010
NIELSEN KURT ANKERDirector72006–2010
PENHOET EDWARDDirector72006–2010
SORENSEN LARS REBIENDirector42006–2009
Hamby Darren ROfficerSr. VP, HR & Corp Svcs; Sr. VP, Human Resources102007–2010
KAYE CHARLES RTenPercentOwner92007–2010
LANDY JOSEPHTenPercentOwner92007–2010
WARBURG PINCUS & COTenPercentOwner92007–2010
WARBURG PINCUS EQUITY PARTNERS LPTenPercentOwner92007–2010
WARBURG PINCUS LLCTenPercentOwner92007–2010
Warburg Pincus Partners LLCTenPercentOwner92007–2010
Franklin Heather LOfficerSr. VP, Business Development62008–2010
Zaruby Stephen WOfficerPresident52009–2010
Ramos EleanorOfficerSr. VP, Chief Medical Officer52009–2010
Miller Dennis M.OfficerSr VP, Resrch & Preclin Devl62009–2010
NOVO NORDISK A SOther; TenPercentOwner22010
Montgomery Alan BruceDirector22010
Jorgensen Lars FruergaardDirector32010
BRISTOL MYERS SQUIBB COTenPercentOwner22010
Zeus Acquisition CorpTenPercentOwner22010

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorZYMOGENETICS, INCWAForm 5500 (employee benefit plans)name and state
Plan sponsorZYMOGENETICS, INC.WAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientZYMOGENETICS, INC.WAFederal spending (USAspending)name and state
Lobbying clientZYMOGENETICSWAFederal lobbying (LDA)name and state
NonprofitTOASTMASTERS INTERNATIONALWANonprofits (IRS Form 990)same street address and ZIP code, 1201 EASTLAKE AVE E 98102 (FUZZY: a shared address, not proof of a shared organization)
Patent assigneeZYMOGENETICS INC.WAPatents (USPTO)name and state
SEC filerZYMOGENETICS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerZymoGenetics, Inc.WATrademarks (USPTO)name and state
Form 5500 plan sponsorZYMOGENETICS, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), WA first:

More with this interest.

In other datasets, the same topic (Health) in WA:

Interests: Biological Products, (No Diagnostic Substances) · Health